Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative

British Journal of Cancer

Volumn 88, Issue 12, 2003, Pages 1987-1994

  Di Benedetto, M ^a   Starzec, A ^a   Vassy, R ^a   Perret, G Y ^a   Crepin M ^a,b   Kraemer, M ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Aponecrosis; Phenylacetate carboxymethyl benzylamide dextran (NaPaC); Tumour angiogenesis; Vascular endothelial growth factor (VEGF)

Indexed keywords

DEXTRAN DERIVATIVE; PHENYLACETATE CARBOXYMETHYLBENZYLAMIDE DEXTRAN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DENSITY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG STRUCTURE; HUMAN; HUMAN CELL; MICROVASCULATURE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; DEXTRANS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0038235980     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600985     Document Type: Article

References (30)

1. Avramoglou T, Bagheri R, Chaubet F, Crépin M, Dehri-Correia L, Di Benedetto M, Gervelas C, Huynh R, Jozefonvicz J (2001) Composition pharmacéutique contenant au moins un polymère associé ou conjugué à au moins un seul acide phenylalkylcarboxylique. Polymères conjugués et leurs application. Patent No. WO 0191742
2. Alroy J, Goyal V, Skutelsky E (1987) Lectin histochemistry of mammalian endothelium. Histochemistry 86: 603-607
3. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D (1999) Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284: 808-812
4. Blood CH, Zetter BR (1990) Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1032: 89-118
5. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407: 249-257
6. Cascinu S, Staccioli MP, Gasparini G, Giordani P, Catalano V, Ghiselli R, Rossi C, Baldelli AM, Graziano F, Saba V, Muretto P, Catalano G (2000) Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer. Clin Cancer Res 6: 2803-2807
7. Di Benedetto M, Kourbali Y, Starzec A, Vassy R, Jozefonvicz J, Perret GY, Crepin M, Kraemer M (2001) Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice. Br J Cancer 85: 917-923
8. Di Benedetto M, Starzec A, Colombo BM, Briane D, Perret GY, Kraemer M, Crepin M (2002) Aponecrotic, antiangiogenic and antiproliferative effects of a novel dextran derivative on breast cancer growth in vitro and in vivo. Br J Pharmacol 135: 1851-1858
9. Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM (1999) Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hypermeability in angiogenesis. In Vascular Growth Factors and Angiogenesis, Claesson-Welsch L (ed) pp 97-132. Berlin: Springer-Verlag
10. Eberhard A, Kahlet S, Goede V, Hemmerlein B, Plate KH, Augustin H (2001) Heterogeneity of angiogeneis and blood vessel maturation in human tumors: implication of antiangiogenic tumor therapies. Cancer Res 60: 1388-1393
11. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1: 27-31
12. Formigli L, Pappuci L, Tani A, Schiavone N, Tempestini A, Orlandini GE, Capaccioli S, Orlandini SZ (2000) Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol 182: 41-49
13. Izumi Y, Xu L, di Tomaso E, Fukumura D, Jain RK (2002) Herceptin acts as an anti-angiogenic coktail. Nature 416: 279-280
14. Krantz A, Mattfeldt T, Waltenberger J (1999) Molecular mediators of tumor angiogenesis: enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer. Int J Cancer 84: 293-298
15. Leenders W, Küster B, de Wall R M W (2002) Vessel co-option: how tumor obtain blood supply in the absence of sprouting angiogenesis. Endothelium 9: 83-87
16. 123I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy. Int J Cancer 91: 789-796
17. Melnyk O, Shuman MC, Kim KJ (1996) Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from ots effect on primary tumor growth. Cancer Res 56: 921-924
18. Mori A, Shigeki A, Furutani M, Hanaki K, Takeda Y, Moriga T, Kondo Y, Gorrin Rivas MJ, Imamura M (1999) Vascular endothelial growth factor-induced tumor angiogenesis and tumorigenicity in relation to metastasis in a HT1080 human fibrosarcoma cell model. Int J Cancer 80: 738-743
19. Mosmann T (1983) Rapid colorimetric assay for cell growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63
20. Myoken Y, Kayada Y, Okamoto T, Sato GH, Sato JD (1991) Vascular endothelial cell growth factor (VEGF) produced by A431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc Natl Acad Sci USA 88: 5819-5823
21. Pezzela F, Pastorino U, Tagliabue E (1997) Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 151: 739-752
22. Ramanujan S, Koenig GC, Padera TP, Stoll BR, Jain K (2000) Local imbalance of proangiogenic and antiangiogenic factors: a potential mechanism of focal necrosis and dormancy in tumors. Cancer Res 60: 1442-1448
23. Ryschich E, Schmidt J, Hämmerling GJ, Klar E, Ganss (2002) Transformation of the microvascular system during multistage tumorigenesis. Int J Cancer 97: 719-725
24. Scatchard G (1986) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 261: 4660-4662
25. Senger DR, Peruzzi CA, Feder J, Dvorak HE (1986) A higly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46: 5629-5633
26. Shen GH, Ghazizadeh M, Kwanami O, Shimizu H, Jin E, Araki T, Sugisaki Y (2000) Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma. Br J Cancer 83: 196-203
27. 165 via its exon 7-encoded domain. J Biol Chem 271: 5761-5767
28. Weibel ER (1979) Practical methods for biological morphometry. In Stereological Methods, Weibel ER (ed) 1, pp 1-415. London: Academic Press
29. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 324: 1-8
30. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, Stables J, Stephens T, Wallace J (1998) United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). Br J Cancer 77: 1-10